Investor FAQs

Investor FAQs

Show all

Investor FAQ's

Precision Therapeutics common shares are traded on Nasdaq Capital Market under the ticker symbol AIPT.
Precision Therapeutics was incorporated under the name BioDrain Medical, Inc. on April 23, 2002, in the state of Minnesota.
Precision Therapeutics changed from Skyline Medical, Inc. effective February 2, 2018.
Precision Therapeutics became a public company on October 19, 2009. It began trading on the Nasdaq in August 2015.
Price information as well as other information regarding the Precision Therapeutics stock is provided by its stock exchange platform and can be found on our Stock Information page.
Through a licensed stock broker or by using an online trading account.
As of the last quarterly filing, there were 5,203,428 shares outstanding.  For an updated shares outstanding figure, please visit our SEC Filings.
Corporate Stock Transfer, Inc. 3200 Cherry Creek South Drive, Suite 430, Denver, CO 80209; Tel-303-282-4800.
Please contact the Company’s transfer agent regarding your stock certificate.
Precision Therapeutics' fiscal year ends on December 31.
Please visit the Financial Information section of our website to obtain the latest Annual Report.
Precision Therapeutics' CUSIP number is 83084T101.
2915 Commers Drive, Suite 900
Eagan, MN 55121
 
Precision Therapeutics' independent auditors are Olsen Thielen & Com, Ltd., 2675 Long Lake Road, St. Paul MN 55113; Tel-651-621-8338.
Martin Rosenbaum, Maslon, Edelman, Borman & Brand, LLP, 3300 Wells Fargo Center, 90 South Seventh Street, Minneapolis, MN 55402, Tel-612-672-8300.
Please contact: Elizabeth Barker

KCSA Strategic Communications


ebarker@kcsa.com